Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The usual recommended dose of sotorasib is 960 mg (8 tablets x 120 mg) once daily, taken on an empty stomach at least 1 hour before or 2 hours after eating. Specific usage must be ···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：40
Sotorasib is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, specification, purchasing channel, and···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：37
Lumykras (generic name: Sotorasib) is a prescription targeted therapy drug for non-small cell lung cancer (NSCLC) that targets a specific gene mutation (KRAS G12C). Its price is in···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：37
The price of Sotorasib varies significantly depending on the region, purchasing channel, and specification. For specific prices, please refer to the actual selling prices at hospit···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：38
The side effects of Avatrombopag are generally manageable, with most being mild to moderate in severity. However, risk assessment should be based on individual patient conditions a···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：33
Avatrombopag is an oral medication used to treat thrombocytopenia (low platelet count) associated with chronic liver disease or chemotherapy. Its common side effects include headac···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：33
The price of Avatrombopag varies significantly, typically ranging from a few hundred to several thousand RMB per box. The specific price mainly depends on the version of the drug (···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：35
Lucius Pharmaceuticals Avatrombopag is a prescription medication used to treat thrombocytopenia associated with chronic liver disease or immune thrombocytopenia. The current cost i···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：37
Eltrombopag (generic name: Eltrombopag Olamine Tablets) prices vary depending on factors such as specifications, place of origin, and purchasing channels. This medication is a pres···【more】
Article source：Captain MedicineRelease date：2026-02-13Recommended：55
Eltrombopag is an oral thrombopoietin receptor agonist that provides an effective treatment option for thrombocytopenia caused by various reasons.Has eltrombopag been launched?Eltr···【more】
Article source：Captain MedicineRelease date：2026-02-13Recommended：50
The immunotherapy drug Promacta (eltrombopag) has recently been granted an expanded indication label by the U.S. FDA. It is now approved for use in combination with standard immuno···【more】
Article source：Captain MedicineRelease date：2026-02-13Recommended：53
Severe Aplastic Anemia (SAA) is a relatively serious and rare blood disorder. If left untreated promptly, the condition can be severe and potentially fatal, and current initial tre···【more】
Article source：Captain MedicineRelease date：2026-02-13Recommended：56
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1592025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3992024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：1532025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1712025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1532025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1872025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1682025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1632025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
